AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the
“Company”), a land-based aquaculture company utilizing technology
to enhance productivity and sustainability, today announced the
Company’s financial results for the fourth quarter and full year
ended December 31, 2021.
Fourth Quarter and Full Year 2021 Highlights and Recent
Developments
- Successfully launched the first commercial scale harvests and
sales of the Company’s genetically engineered (“GE”) Atlantic
salmon from both its Indiana and Rollo Bay farm sites in June.
- Harvested 91 tons of GE Atlantic salmon and generated $340,900
in revenue from the sale of 101,700 pounds of salmon to customers
during the fourth quarter. Harvest revenue for the full year 2021
totaled $783,000.
- Sales of non-transgenic eggs and fry increased to $76,700 in
the fourth quarter and totaled $391,800 for the full year.
- Fortified balance sheet with $127.1 million in gross proceeds
from the closing of an underwritten public offering of common stock
in February 2021.
- Received approval from the Board of the Toledo-Lucas County
Port Authority for the issuance of up to $300 million in municipal
bonds to support the construction financing for the planned Ohio
farm.
- Identified the appropriate metrics, initiated data collection
and started the build-out of the platform necessary for our
Environmental, Social, and Governance (“ESG”) integrated reporting
capability.
- Subsequent to year-end, commenced critical pre-construction
activities for the Company’s Pioneer, Ohio farm site, including
setting surveyor benchmarks, construction of roadways and preparing
on-site energy infrastructure.
Management Commentary
“The fourth quarter of 2021 was highlighted by the continued
ramp up of commercial production with the harvest and sale of our
proprietary GE salmon at our Albany, Indiana and Prince Edward
Island, Canada farms,” said Sylvia Wulf, Chief Executive Officer of
AquaBounty. “During the quarter we harvested 91 tons of salmon, an
8% improvement over the third quarter, enabled by production
capacity improvements and the hiring of additional staff.
Commercial interest in our nutritious salmon, which is free of
antibiotics and other contaminants, has been impressive and we
continue to receive orders for the entire output from our
farms.
“To meet the rising market demand for our GE salmon, we are
highly focused on the start of construction of our
transformational, next-generation 10,000 metric ton farm in
Pioneer, Ohio. Pre-construction activities have already commenced,
including the construction of roadways and on-site energy
infrastructure, as well as the setting of surveyor’s benchmarks
ahead of grading work. We will soon be announcing an official
groundbreaking ceremony and expect construction to commence in
early spring. Our timeline for stocking our salmon eggs is still on
track to occur in late 2023.
“As we have mentioned previously, the Toledo-Lucas County Port
Authority has been extremely supportive of our Ohio farm and last
November, its Board approved the issuance of up to $300 million in
tax-exempt and taxable bonds to support our project. We expect to
complete the bond placement process in the next three months with
Wells Fargo Corporate and Investment Banking as our
underwriter.
“Looking ahead, we are focused on continuing our momentum in
increasing our harvest output, onboarding more new customers and
growing our revenue. We are excited about commencing construction
on our Ohio farm which is planned to generate roughly eight times
the output capacity of our Indiana farm. As we begin this new year,
we are extremely confident in the market acceptance of our salmon
and will strive to create long term value for our shareholders,”
concluded Wulf.
Financial Summary through December 31, 2021
- Revenue for the year ended December 31, 2021 was $1.17 million,
compared to $128 thousand for the year ended December 31, 2020.
Harvests at the Indiana and PEI farms commenced in June 2021 and
weekly output is ramping steadily.
- Operating expenses for full year 2021 were $23.3 million,
compared to $16.4 million in the prior year. The increase reflects
the growth in headcount, production expenses and third-party
processing and transportation costs at the farms, as well as
increases in corporate and marketing expenses.
- Net loss for the year ended December 31, 2021 was $22.3
million, compared to $16.4 million in the prior year.
- Cash, cash equivalents, marketable securities and restricted
cash totaled $191.2 million as of December 31, 2021, compared
with $96.3 million as of December 31, 2020.
About AquaBounty
At AquaBounty Technologies, Inc. (NASDAQ: AQB), we believe we
are a leader in aquaculture leveraging decades of technology
expertise to deliver game-changing solutions that address food
insecurity and climate change issues, while improving efficiency,
sustainability and profitability. AquaBounty provides fresh
Atlantic salmon to nearby markets by raising its fish in carefully
monitored land-based fish farms through a safe, secure and
sustainable process. The Company’s land-based Recirculating
Aquaculture System (“RAS”) farms, located in Indiana, United States
and Prince Edward Island, Canada, are close to key consumption
markets and are designed to prevent disease and to include multiple
levels of fish containment to protect wild fish populations.
AquaBounty is raising nutritious salmon that is free of antibiotics
and other contaminants and provides a solution resulting in a
reduced carbon footprint and no risk of pollution to marine
ecosystems as compared to traditional sea-cage farming. For more
information on AquaBounty, please visit www.aquabounty.com or
follow us on Facebook, Twitter, LinkedIn and Instagram.
Forward-Looking Statements
This press release contains “forward-looking statements” as
defined in the Private Securities Litigation Reform Act of 1995, as
amended, including regarding the anticipated size of AquaBounty’s
proposed facility in Ohio; production capacity; timing of
construction, permits, regulatory approvals, or commercial
stocking; cost of construction; amount to be invested in the
project, ability to produce eggs, fry, and broodstock;
future revenue streams; onboarding customers, pricing and
profitability. The forward-looking statements in this press
release are neither promises nor guarantees, and you should not
place undue reliance on these statements because they involve
significant risks and uncertainties about AquaBounty. AquaBounty
may use words such as “expect,” “anticipate,” “project,” “intend,”
“slated to,” “plan,” “aim,” “believe,” “seek,” “estimate,” “can,”
“focus,” “will,” and “may” and similar expressions to identify such
forward-looking statements. Among the important factors that could
cause actual results to differ materially from those indicated by
such forward-looking statements are risks relating to, among other
things, whether AquaBounty and its partners will consummate the
proposed bond financing; the final terms of the financing, market
and other conditions; the satisfaction of closing conditions; the
impact of the bond offering on AquaBounty’s financial condition,
credit rating and stock price; whether AquaBounty will need to and
be able to raise additional equity capital; whether AquaBounty will
be able to service the bond commitments, be able to secure required
regulatory approvals and permits, be able to profitably construct
and operate the farm; AquaBounty’s business and financial
condition, and the impact of general economic, public health,
industry or political conditions in the United States or
internationally. Forward-looking statements speak only as of
the date hereof, and, except as required by law, AquaBounty
undertakes no obligation to update or revise these forward-looking
statements. For additional information regarding these and other
risks faced by us, please refer to our public filings with the
Securities and Exchange Commission (“SEC”), available on the
Investors section of our website at www.aquabounty.com and on the
SEC’s website at www.sec.gov.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy the bonds described herein, nor
shall there be any sale of these bonds in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful.
Company Contact:AquaBounty TechnologiesDave
ConleyCorporate Communications(613) 294-3078
Investor Relations:Greg Falesnik or Luke
ZimmermanMZ Group - MZ North America(949)
259-4987AQB@mzgroup.us
AquaBounty Technologies,
Inc.Condensed Consolidated Balance
Sheets
|
|
|
|
|
|
|
As of December 31, |
|
2021 |
|
|
2020 |
|
Assets |
|
|
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
$ |
88,454,988 |
|
|
$ |
95,751,160 |
|
Marketable securities |
|
101,773,781 |
|
|
|
— |
|
Inventory, net |
|
1,259,910 |
|
|
|
1,525,377 |
|
Prepaid expenses and other current assets |
|
1,536,484 |
|
|
|
405,370 |
|
Total current assets |
|
193,025,163 |
|
|
|
97,681,907 |
|
|
|
|
|
|
|
Property, plant and equipment,
net |
|
33,815,119 |
|
|
|
26,930,338 |
|
Right of use assets, net |
|
284,320 |
|
|
|
341,997 |
|
Intangible assets, net |
|
231,842 |
|
|
|
245,546 |
|
Restricted cash |
|
1,000,000 |
|
|
|
500,000 |
|
Other
assets |
|
79,548 |
|
|
|
76,715 |
|
Total assets |
$ |
228,435,992 |
|
|
$ |
125,776,503 |
|
|
|
|
|
|
|
Liabilities and
stockholders' equity |
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
Accounts payable and accrued liabilities |
$ |
4,317,615 |
|
|
$ |
1,176,802 |
|
Accrued employee compensation |
|
874,589 |
|
|
|
583,301 |
|
Current debt |
|
627,365 |
|
|
|
259,939 |
|
Other current liabilities |
|
66,269 |
|
|
|
62,483 |
|
Total current liabilities |
|
5,885,838 |
|
|
|
2,082,525 |
|
|
|
|
|
|
|
Long-term lease
obligations |
|
224,058 |
|
|
|
290,327 |
|
Long-term debt, net |
|
8,523,333 |
|
|
|
8,528,490 |
|
Total liabilities |
|
14,633,229 |
|
|
|
10,901,342 |
|
|
|
|
|
|
|
Commitments and
contingencies |
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
Common stock, $0.001 par value, 80,000,000 shares authorized at
December 31, |
|
|
|
|
|
2021 and 2020; 71,025,738 and 55,497,133 shares outstanding at
December 31, 2021 and 2020, respectively |
|
71,026 |
|
|
|
55,497 |
|
Additional paid-in capital |
|
384,852,107 |
|
|
|
263,629,116 |
|
Accumulated other comprehensive loss |
|
(255,588 |
) |
|
|
(267,258 |
) |
Accumulated deficit |
|
(170,864,782 |
) |
|
|
(148,542,194 |
) |
Total stockholders' equity |
|
213,802,763 |
|
|
|
114,875,161 |
|
|
|
|
|
|
|
Total
liabilities and stockholders' equity |
$ |
228,435,992 |
|
|
$ |
125,776,503 |
|
AquaBounty Technologies,
Inc.Condensed Consolidated Statements of
Operations and Comprehensive Loss
|
|
|
|
|
|
|
Years endedDecember 31, |
|
2021 |
|
|
2020 |
|
Revenues |
|
|
|
|
|
Product revenues |
$ |
1,174,832 |
|
|
$ |
127,663 |
|
|
|
|
|
|
|
Costs and
expenses |
|
|
|
|
|
Product costs |
|
10,786,072 |
|
|
|
6,680,012 |
|
Sales and marketing |
|
1,261,764 |
|
|
|
533,428 |
|
Research and development |
|
2,145,548 |
|
|
|
2,364,610 |
|
General and administrative |
|
9,103,213 |
|
|
|
6,797,443 |
|
Total costs and expenses |
|
23,296,597 |
|
|
|
16,375,493 |
|
|
|
|
|
|
|
Operating
loss |
|
(22,121,765 |
) |
|
|
(16,247,830 |
) |
|
|
|
|
|
|
Other income
(expense) |
|
|
|
|
|
Interest expense |
|
(316,442 |
) |
|
|
(152,367 |
) |
Other income (expense), net |
|
115,619 |
|
|
|
212 |
|
Total other income (expense) |
|
(200,823 |
) |
|
|
(152,155 |
) |
|
|
|
|
|
|
Net loss |
$ |
(22,322,588 |
) |
|
$ |
(16,399,985 |
) |
|
|
|
|
|
|
Other comprehensive
income (loss): |
|
|
|
|
|
Foreign currency |
|
51,771 |
|
|
|
92,902 |
|
Unrealized losses on marketable securities |
|
(40,101 |
) |
|
|
— |
|
Total other comprehensive income |
|
11,670 |
|
|
|
92,902 |
|
|
|
|
|
|
|
Comprehensive loss |
$ |
(22,310,918 |
) |
|
$ |
(16,307,083 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per
share |
$ |
(0.32 |
) |
|
$ |
(0.45 |
) |
Weighted average number of
common shares - |
|
|
|
|
|
basic and diluted |
|
69,428,061 |
|
|
|
36,347,398 |
|
AquaBounty Technologies,
Inc.Condensed Consolidated Statements of Cash
Flows
|
|
|
|
|
|
|
Years EndedDecember 31, |
|
2021 |
|
|
2020 |
|
Operating activities |
|
|
|
|
|
Net loss |
$ |
(22,322,588 |
) |
|
$ |
(16,399,985 |
) |
Adjustment to reconcile net
loss to net cash used in |
|
|
|
|
|
operating activities: |
|
|
|
|
|
Depreciation and amortization |
|
1,787,564 |
|
|
|
1,494,596 |
|
Share-based compensation |
|
394,237 |
|
|
|
436,691 |
|
Other non-cash charge |
|
17,386 |
|
|
|
44,339 |
|
Changes in operating assets
and liabilities: |
|
|
|
|
|
Inventory |
|
267,833 |
|
|
|
(282,260 |
) |
Prepaid expenses and other assets |
|
(1,138,691 |
) |
|
|
(74,621 |
) |
Accounts payable and accrued liabilities |
|
230,712 |
|
|
|
145,607 |
|
Accrued employee compensation |
|
291,288 |
|
|
|
346,812 |
|
Net cash used in operating activities |
|
(20,472,259 |
) |
|
|
(14,288,821 |
) |
|
|
|
|
|
|
Investing
activities |
|
|
|
|
|
Purchases of property, plant
and equipment |
|
(5,668,696 |
) |
|
|
(3,975,135 |
) |
Deposits on equipment
purchases |
|
(45,111 |
) |
|
|
(349,847 |
) |
Proceeds from sale
equipment |
|
— |
|
|
|
99,816 |
|
Purchases of marketable
securities, net |
|
(101,813,882 |
) |
|
|
— |
|
Proceeds from legal
settlement, net |
|
— |
|
|
|
1,014,008 |
|
Other
investing activities |
|
(11,010 |
) |
|
|
(27,253 |
) |
Net cash used in investing activities |
|
(107,538,699 |
) |
|
|
(3,238,411 |
) |
|
|
|
|
|
|
Financing
activities |
|
|
|
|
|
Proceeds from issuance of
debt |
|
606,453 |
|
|
|
4,221,130 |
|
Payment of debt issuance
costs |
|
— |
|
|
|
(91,620 |
) |
Repayment of term debt |
|
(272,102 |
) |
|
|
(70,826 |
) |
Proceeds from the issuance of
common stock, net |
|
119,120,437 |
|
|
|
104,625,615 |
|
Proceeds from the exercise of stock options and warrants |
|
1,723,846 |
|
|
|
2,318,709 |
|
Net cash provided by financing activities |
|
121,178,634 |
|
|
|
111,003,008 |
|
|
|
|
|
|
|
Effect
of exchange rate changes on cash, cash equivalents and restricted
cash |
|
36,152 |
|
|
|
(23,360 |
) |
Net change in cash, cash equivalents and restricted cash |
|
(6,796,172 |
) |
|
|
93,452,416 |
|
Cash,
cash equivalents and restricted cash at beginning of period |
|
96,251,160 |
|
|
|
2,798,744 |
|
Cash, cash equivalents and restricted cash at end of
period |
$ |
89,454,988 |
|
|
$ |
96,251,160 |
|
|
|
|
|
|
|
Reconciliation of
cash, cash equivalents and restricted cash reported |
|
|
|
|
|
in the consolidated balance sheet: |
|
|
|
|
|
Cash and cash equivalents |
$ |
88,454,988 |
|
|
$ |
95,751,160 |
|
Restricted cash |
|
1,000,000 |
|
|
|
500,000 |
|
Total cash, cash equivalents and restricted cash |
$ |
89,454,988 |
|
|
$ |
96,251,160 |
|
|
|
|
|
|
|
Supplemental
disclosure of cash flow information and |
|
|
|
|
|
non-cash transactions: |
|
|
|
|
|
Interest paid in cash |
$ |
299,056 |
|
|
$ |
114,893 |
|
Property and equipment included in accounts payable and accrued
liabilities |
$ |
2,926,016 |
|
|
$ |
23,600 |
|
AquaBounty Technologies (NASDAQ:AQB)
Historical Stock Chart
From Jan 2025 to Feb 2025
AquaBounty Technologies (NASDAQ:AQB)
Historical Stock Chart
From Feb 2024 to Feb 2025